ARCHIVES

NCAB Committee Close To Definition Of QRA

This article is from The Cancer Letter archive.

Vol. 09 No. 06 | February 11, 1983

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

ASCO Annual Meeting: NCI goals: Expand Clinical Trials, Build Informatics Network

May 30, 1997

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

Revlimid Also Demonstrates Response in Mantle Cell

July 29, 2011

NCI Support Crucial for Israel cancer Studies; Weizmann Top Recipient

June 17, 1977

In Brief: Lawyers Halt Reference Chemical Distribution To Grantees, Threaten To Stop Viruses, Animals

September 2, 1977